tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

GT Biopharma Inc

GTBP
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.290USD
-0.018-5.69%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
1.76M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

GT Biopharma Inc

0.290
-0.018-5.69%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

GTBP ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด GT Biopharma Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

GT Biopharma Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 15, 2026
EPS / ์˜ˆ์ƒ
-0.11/-0.08
์ˆ˜์ต / ์˜ˆ์ƒ
0.00/0.00
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
--
--
EPS(YoY)
-6.25
9.93%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/31
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
66.38%-0.11
-33.16%-2.23
45.84%-0.83
74.73%-0.55
79.84%-0.33
22.02%-1.67
13.60%-1.53
-45.67%-2.17
-841.64%-1.64
58.65%-2.14
---1.77
---1.49
---0.17
---5.19
----
----
----
----
----
----
์ˆ˜์ต
--0.00
----
----
----
--0.00
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
์ˆœ์ด์ต
-334.15%-3.37M
-665.48%-28.90M
4.49%-3.26M
59.08%-1.52M
65.75%-776.00K
-27.45%-3.77M
-41.18%-3.41M
-86.24%-3.71M
-898.24%-2.27M
46.96%-2.96M
64.89%-2.42M
33.13%-1.99M
95.83%-227.00K
69.02%-5.58M
-26.19%-6.88M
38.72%-2.98M
81.67%-5.44M
-20.69%-18.02M
-89.60%-5.45M
72.10%-4.86M
๋ถ€์ฑ„๋น„์œจ
----
--0.00%
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
--0.00
----
----
----
--0.00
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
์˜์—… ์ด์ต
-47.41%-2.85M
-48.68%-5.59M
6.16%-3.38M
61.26%-1.51M
37.50%-1.93M
-18.78%-3.76M
-15.44%-3.60M
-7.87%-3.91M
15.66%-3.09M
45.17%-3.17M
55.55%-3.12M
-20.14%-3.62M
32.65%-3.67M
68.21%-5.78M
-17.95%-7.02M
31.20%-3.01M
81.24%-5.44M
-729.67%-18.18M
-206.12%-5.95M
-181.19%-4.38M
์ˆœ์ด์ต
-334.15%-3.37M
-665.48%-28.90M
4.49%-3.26M
59.08%-1.52M
65.75%-776.00K
-27.45%-3.77M
-41.18%-3.41M
-86.24%-3.71M
-898.24%-2.27M
46.96%-2.96M
64.89%-2.42M
33.13%-1.99M
95.83%-227.00K
69.02%-5.58M
-26.19%-6.88M
38.72%-2.98M
81.67%-5.44M
-20.69%-18.02M
-89.60%-5.45M
72.10%-4.86M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
276.07%10.00M
91.54%8.11M
-36.07%4.32M
-23.13%7.12M
-73.11%2.66M
-69.89%4.23M
-57.89%6.76M
-48.58%9.27M
-50.42%9.88M
-15.13%14.06M
-23.09%16.05M
-24.75%18.02M
-26.68%19.94M
-48.52%16.56M
-41.70%20.87M
-39.48%23.95M
-1.63%27.19M
468.26%32.17M
4197.48%35.80M
3974.87%39.57M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-33.59%2.42M
-60.71%2.32M
-71.66%1.32M
-38.63%2.31M
-20.91%3.64M
-11.02%5.90M
-8.41%4.66M
-22.38%3.76M
12.86%4.60M
34.33%6.63M
1.29%5.09M
-43.75%4.84M
-57.11%4.08M
-51.87%4.94M
28.12%5.03M
162.82%8.61M
162.08%9.50M
-70.77%10.26M
-87.22%3.92M
-88.53%3.28M
์ด ์ž์‚ฐ
276.07%10.00M
91.54%8.11M
-36.07%4.32M
-23.13%7.12M
-73.18%2.66M
-70.00%4.23M
-58.14%6.76M
-48.93%9.27M
-50.65%9.91M
-15.70%14.11M
-23.36%16.15M
-24.93%18.14M
-26.80%20.09M
-47.97%16.74M
-41.14%21.07M
-38.91%24.17M
-0.74%27.44M
468.26%32.17M
3803.82%35.80M
3622.20%39.57M
๋ถ€์ฑ„ ์ด๊ณ„
-33.59%2.42M
-60.71%2.32M
-71.66%1.32M
-38.63%2.31M
-20.91%3.64M
-11.02%5.90M
-24.11%4.66M
-41.09%3.76M
-34.59%4.60M
32.61%6.63M
20.05%6.14M
-26.91%6.38M
-27.12%7.03M
-51.24%5.00M
30.47%5.12M
166.48%8.73M
166.13%9.65M
-70.77%10.26M
-87.22%3.92M
-88.53%3.28M
์ž๋ณธ ์ด๊ณ„
873.47%7.58M
446.53%5.79M
43.06%3.00M
-12.55%4.82M
-118.45%-980.00K
-122.34%-1.67M
-79.04%2.10M
-53.18%5.51M
-59.30%5.31M
-36.29%7.48M
-37.29%10.01M
-23.81%11.76M
-26.62%13.05M
-46.44%11.73M
-49.95%15.95M
-57.46%15.44M
-25.93%17.79M
174.44%21.91M
207.05%31.88M
231.97%36.29M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-12.08%-2.47M
-62.93%-4.02M
-34.34%-3.68M
14.76%-3.01M
47.11%-2.20M
-20.57%-2.47M
-39.36%-2.74M
-82.74%-3.54M
-43.26%-4.16M
52.37%-2.05M
32.69%-1.96M
30.55%-1.94M
44.28%-2.91M
-16.01%-4.30M
25.73%-2.92M
35.03%-2.79M
-41.56%-5.21M
-92.27%-3.71M
-130.98%-3.93M
-25.71%-4.29M
์ˆœํˆฌ์ž
----
----
----
----
-100.00%0.00
-99.79%1.00K
-100.05%-1.00K
195.78%7.86M
172.03%5.03M
-93.63%478.00K
7280.00%1.84M
145.79%2.66M
-297.82%-6.99M
150.95%7.51M
100.10%25.00K
--1.08M
--3.53M
--2.99M
---26.03M
----
์ˆœ์žฌ๋ฌดํ™œ๋™
643.51%4.58M
--8.30M
--977.00K
97.48%5.88M
--616.00K
--0.00
--0.00
--2.98M
-100.00%0.00
100.00%0.00
--0.00
100.00%0.00
--6.27M
---1.00K
-100.00%0.00
-101.37%-223.00K
-100.00%0.00
-100.00%0.00
-88.58%137.00K
281.44%16.24M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

GT Biopharma Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 8.11M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 91.54์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, GT Biopharma Inc์˜ ์ด์ž์‚ฐ์€ 8.11M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 91.54์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, GT Biopharma Inc์˜ ์ด๋ถ€์ฑ„๋Š” 2.32M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -60.71์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, GT Biopharma Inc์˜ ์ด์ž๋ณธ์€ 5.79M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 446.53์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, GT Biopharma Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -12.42M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 13.52์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, GT Biopharma Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 15.78M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 430.07์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -6.25์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 9.93์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -34.45M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -161.73์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -1674.31์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -269.16์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -459.62์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -220.24์ž…๋‹ˆ๋‹ค.

GT Biopharma Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
GT Biopharma Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -12.42M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 13.52์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ